LEADER 02981nam  2200589 a 450 
001 9910461169603321
005 20200520144314.0
010   $a1-60805-162-5
035   $a(CKB)2670000000122502
035   $a(EBL)864219
035   $a(OCoLC)779141406
035   $a(SSID)ssj0000671840
035   $a(PQKBManifestationID)11365108
035   $a(PQKBTitleCode)TC0000671840
035   $a(PQKBWorkID)10625153
035   $a(PQKB)10466950
035   $a(MiAaPQ)EBC864219
035   $a(Au-PeEL)EBL864219
035   $a(CaPaEBR)ebr10504668
035   $a(EXLCZ)992670000000122502
100   $a20111125d2011      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aAnti-angiogenesis drug discovery and development$b[electronic resource] /$feditors, Atta-ur-Rahman, M. Iqbal Choudhary
210   $a[Oak Park, Ill.?] $cBentham eBooks$d[2011]
215   $a1 online resource (197 p.)
225 0 $aAnti-angiogenesis drug discovery and development,$x2210-268X ;$vv. 1
300   $aDescription based upon print version of record.
311   $a1-60805-648-1 
320   $aIncludes bibliographical references and index.
327   $aCONTENTS; Preface; Contributors; Antiangiogenic Treatment of Hematological Tumors; Multiligands/Rage Axis: An Emerging Actor in Tumour Angiogenesis; Ginsenoside Rg3 and Rh2: The Anti-Cancer and Anti-Angiogenic Saponins from Ginseng; Antiangiogenic Therapy for Cardiovascular Diseases; Role of Phosphoinositide 3-Kinases and Angiogenesis in Cardiovascular Diseases; Redox Regulation of Angiogenesis: NADPH Oxidase as a Drug Target; Thymidine Phosphorylase Inhibitors; Neurological Complications of Antiangiogenic Therapy; Autoimmunity and Angiogenesis; Author Index
330   $aThe inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results.Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery scien
606   $aNeovascularization inhibitors
606   $aNeovascularization
606   $aDrug development
608   $aElectronic books.
615  0$aNeovascularization inhibitors.
615  0$aNeovascularization.
615  0$aDrug development.
676   $a600
701   $aRahman$b Atta-ur-$090829
701   $aChoudhary$b M. Iqbal$093453
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910461169603321
996   $aAnti-angiogenesis drug discovery and development$92048518
997   $aUNINA